AMR Ireland

Fintan Kelleher (Founder)

[AMR Action Fund @AMRActionFund]

"Candida auris can contaminate just about any surface imaginable, from intravenous lines and feeding tubes to bedsheets, doctors’ coats, and sinks." Learn more about the rapid rise and troubling future of this fungal pathogen: https://t.co/jBvmSQzkWI #AMR

[Working to Fight AMR @WeFightAMR]

Dr. César de la Fuente and his team at @Penn are using AI to identify and test antibiotic candidates within weeks. In an interview with @Contagion_Live, he shares how machine learning can uncover new treatments for drug-resistant infections. Watch: https://t.co/Q84feOOrBo

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

🚩 A major milestone for global antibiotic access!

GARDP signs an agreement with @drreddys to market zoliflodacin—an investigational first-in-class oral antibiotic for #gonorrhoea in 🇹🇭 Thailand and 🇿🇦 South Africa, where GARDP-led Phase 3 trials showed promising results.

🔗 Read more: https://t.co/l3UxIBWACF

#STIs #GARDP #ThisIsBig

[Antimicrobial Resistance Fighter Coalition @AMResistance]

Drug-resistant infections are a hidden threat to cancer patients.

In this podcast by @OneHealthTrust, Dr. Yehoda Martei discusses the urgent need to address #AMR in #CancerCare and protect vulnerable patients.

[EU-JAMRAI @EUjamrai]

“We have different ways to be confronted to AMR: a one time interaction with the healthcare system, a major surgery, a slight injury...”🎯

Yann Heyer from @eupatientsforum highlights the differences between countries and the diversity of areas to face AMR
https://t.co/TBzXLj8VXv

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

50 million lives could be saved by 2050—by improving access to antibiotics. 💊

Drug development is just part of the solution. At GARDP, we’re ensuring antibiotics reach everyone, everywhere. 🤝

📢 Share this post and join the #ThisIsBig campaign.

Together, we can make a BIG difference. 💥

🔗 Learn more: https://t.co/0rqDhG6KLn

#ThisIsBig

[Global Antibiotic R&D Partnership (GARDP) @gardp_amr]

💥#AMR has reached a critical tipping point.

Without urgent action, deaths could rise by 70% by 20250.
We need bold investment in new antibiotics, better access to treatment, and global collaboration—now.

This is BIG.

📢 Share this post and join the #ThisIsBig campaign.

🔗 https://t.co/T59H2mVU9U
#ThisIsBig #AntibioticResistance

[Ineos Oxford Institute for Antimicrobial Research @IneosOxford]

Are hospital sinks hotspots for antibiotic resistant bacteria?

Dr Greg McCallum delivers an engaging talk at the 2025 IOI ECR Conference exploring the spread of antibiotic-resistant bacteria via the hospital sink .

Watch Greg’s talk ➡️ https://t.co/v6nwkTnc75

[Vanessa Carter AMR 🇬🇧🇿🇦 @VCarterAMR]

Before I understood what #AntibioticResistance was, I kept leftover antibiotics just in case I or a family member needed them again

Read a blog👇from @TheAMRNarrative by Dr Labricciosa which explains why this is a no-no!

https://t.co/ZYTqWdQkvi

#AMR #AntimicrobialResistance

[TARGet AMR @TARGet_AMR]

🚨 Coming soon!🚨
💡 Seeing Things Differently: The challenge of delivering trans-disciplinarity within AMR
🎤 Presented by Prof. Paul Flowers, Prof. Will Gaze & Dr Linda Oyama
🗓️ Tuesday 29th April @ 12 – 1pm
👉 Sign up now: https://t.co/llSxAthhhH

[Vanessa Carter AMR 🇬🇧🇿🇦 @VCarterAMR]

Hayley, South Africa 🇿🇦 endured years of medical trauma incl sepsis, #Cdiff, organ failure & multiple surgeries. She lives with constant fear that antibiotics may one day fail to treat her life-threatening infections

Read more 👉https://t.co/y72wJDoQjt

#theAMRnarrative #AMR

[Stephen Cochrane @Cochrane_lab]

@Samantha_Bann @DrLaverty @AMR_Ireland @QUBCCE @qubgradschool @Samantha_Bann now with an actual photo!

[Stephen Cochrane @Cochrane_lab]

Big congrats to @Samantha_Bann on passing her viva today! PhD #3 from group. Thanks to @DrLaverty internal, @AMR_Ireland Fintan Kelleher external and Gary Sheldrake chair. Apologies for forgetting to take photo after 🙈 @QUBCCE @qubgradschool

[AMR Action Fund @AMRActionFund]

The @WHO released its first analysis of the antifungal pipeline. The findings are cause for concern:
-4 new antifungals were approved in last 10 years
-9 agents in clinical development against priority fungal pathogens
- Antifungals with child-friendly formulations are lacking

[Mark Blaskovich @mark_blaskovich]

A 'new and improved' polymxin bites the dust without the opportunity to see if it works 😞..

Spero halts development on another antibiotic in latest reprioritization https://t.co/noHM3aTJXL

[Vanessa Carter AMR 🇬🇧🇿🇦 @VCarterAMR]

Communication matters to patients, especially for a highly-scientific topic like #AntimicrobialResistance or #AMR.

@theAMRnarrative Chair, @FrancyChiara_ recently took part in a panel discussion at the 9th AMR Conference focused exactly on this crucial topic.

#theAMRnarrative

[AMR Action Fund @AMRActionFund]

"Without urgent, coordinated action, we risk a future that, in many ways, would be worse than the Covid-19 pandemic. And in some ways, it already is," write @UKAMREnvoy & @nikolajgilbert #AMR via @Telegraph https://t.co/Nxpfi7Ndgy

[AMR Insights @AmrInsights]

This review explores the integration of #AI across clinical diagnostics, AMR surveillance, and antibiotic discovery to mitigate AMR: https://t.co/A4vDugnMNE

Welcome to attend 'Advancing Data Technologies to Corner AMR (ADTCA) 2025' on 19/20 June, 2025: https://t.co/e35xqMrMA1

[WHO/Europe @WHO_Europe]

Antimicrobial resistance (#AMR) is a global health threat requiring a #OneHealth approach across human, animal, and environmental sectors.

Only half of European countries meet the target for optimal antibiotic use. WHO calls for the responsible use of antibiotics.

#EHR2024

[Vanessa Carter AMR 🇬🇧🇿🇦 @VCarterAMR]

Did you know that the inappropriate use of antibiotics can increase the risk of Clostridioides difficile (C. diff) infection?

In this blog, Dr Francesco M. Labricciosa delves deeper into the topic. Read the blog here:

https://t.co/7UuUxCx6Uh

#theAMRnarrative
#AMR
#AntimicrobialResistance
#Cdiff
#ClostridioidesDifficile